[1]
Emama Arshad Abbasi et al. 2023. IMMUNOLOGICAL BIOMARKERS AND PROGNOSIS OF ENDOMETRIAL CANCER: A META-ANALYSIS. Journal of Population Therapeutics and Clinical Pharmacology. 30, 18 (Nov. 2023), 2048–2059. DOI:https://doi.org/10.53555/jptcp.v30i18.3361.